Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is determine whether a 50,000 IU oral dose of vitamin A delivered
to newborn infants within the first days of life, reduces six-month infant mortality by at
least 15%. The trial will also evaluate whether the survival impact of newborn vitamin A
dosing is modified by concurrent weekly, routine maternal vitamin A or beta-carotene
supplementation during pregnancy through three months postpartum, gestational age and birth
size.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborators:
Access Business Group Bill and Melinda Gates Foundation Canadian International Development Agency Johns Hopkins University United States Agency for International Development (USAID)